Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Stockholders Equity of $301.68 million for the year ending 2025.
- COLLEGIUM PHARMACEUTICAL, INC showed an increase of +31.8% in Stockholders Equity from 2024 to 2025.
- This data is from COLLEGIUM PHARMACEUTICAL, INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $102.42 million | Q3 2015: $93.56 million | Q1 2016: $121.74 million | Q2 2016: $98.66 million | Q3 2016: $74.33 million | Q1 2017: $114.37 million | Q2 2017: $95.51 million | Q3 2017: $96.27 million | Q4 2017: $104.08 million | Q1 2018: $90.82 million | Q2 2018: $82.68 million | Q3 2018: $70.78 million | Q1 2019: $86.35 million | Q2 2019: $85.82 million | Q3 2019: $84.26 million | Q1 2020: $141.06 million | Q2 2020: $155.77 million | Q3 2020: $172.69 million | Q1 2021: $170.04 million | Q2 2021: $253.07 million | Q3 2021: $251.09 million | Q1 2022: $196.08 million | Q2 2022: $197.61 million | Q3 2022: $197.19 million | Q1 2023: $179.73 million | Q2 2023: $200.81 million | Q3 2023: $178.87 million | Q1 2024: $222.17 million | Q2 2024: $216.58 million | Q3 2024: $234.28 million | Q1 2025: $234.43 million | Q2 2025: $232.21 million | Q3 2025: $274.81 million.
- Over the full 14 years of available data (2012 to 2025), COLLEGIUM PHARMACEUTICAL, INC's Stockholders Equity has grown by 591.3%.
- Historical annual values: Fiscal year 2025: $301.68 million | Fiscal year 2024: $228.84 million | Fiscal year 2023: $195.43 million | Fiscal year 2022: $194.84 million | Fiscal year 2021: $202.93 million | Fiscal year 2020: $186.03 million | Fiscal year 2019: $87.43 million | Fiscal year 2018: $91.59 million | Fiscal year 2017: $104.08 million | Fiscal year 2016: $134.91 million | Fiscal year 2015: $85.07 million | Fiscal year 2014: -$89.35 million | Fiscal year 2013: -$68.23 million | Fiscal year 2012: -$61.40 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: